Kintsugi is developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimatelysaving time and lives.

Health Diagnostics

AI/ML

Health Care

Biotechnology

Kintsugi

Grace Chang

Colin Vaz

Prentice Tom

Deepak Ghosh

Albert Ihochi

Product and Engineering

Teams at Kintsugi

Product and Engineering